Today, Shire (SHPG) appointed a new chief financial officer. But the news has gotten lost in the shuffle. The shares are sliding lower today after its rival Roche (RHHBY) unveiled study results that showed its Hemlibra hemophilia drug trial reduced treated bleeds in hemophilia A patients without indicators. The news is an added blow for […]